Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2

Interventions

X-Rays 6Temozolomide 6Specimen Handling 6Nuclear Medicine Department, Hospital 6Magnetic Resonance Spectroscopy 6Biopsy 6Phantoms, Imaging 5Irinotecan 4Cyclophosphamide 4dinutuximab 3ulixertinib 2tipifarnib 2selpercatinib 2saponin QA-21V1 2olaparib 2larotrectinib 2ivosidenib 2fludarabine phosphate 2erdafitinib 2ensartinib 2Topotecan 2trametinib 1tazemetostat 1talazoparib 1palbociclib 1lutetium Lu 177 dotatate 1irinotecan sucrosofate 1fludarabine 1dabrafenib 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neuroblastoma × saponin QA-21V1 × 30 days × Clear all
NCT06057948 2026-06-05

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
94 enrolled
CNS

Neuroblastoma

NCT04936529 2026-05-07

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
286 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡